The Boom of Messaging Apps: Profit Potential With

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
The Boom of Messaging Apps: Profit Potential With Prospective WhatsApp Successor

VANCOUVER, British Columbia, Dec. 11, 2014 (GLOBE NEWSWIRE) -- A race for the most popular messaging app has begun among major internet groups and private equity investors: WhatsApp was bought up by Facebook for USD $22 billion, during the most recent round of financing Snapchat was valued at USD $10 billion, and the Chinese top dog of the messaging world, WeChat, is valued at USD $60 billion. Everyone wants to reach the valuable target market that is 15-30 years of age – and in the future this won't be achieved by using TV or radio, but by using smartphones and messaging applications.

A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=29597

With Fundamental Applications Corp. (CSE:FUN) (WKN: A12DSM/ISIN: CA36080U1003), a company recently listed on the stock exchange, it is possible for the first time to profit from the success of an upcoming messaging application right from the outset. Julian Ing, a pioneer of app development, and his messenger app "Serum".

With Fundamental Applications and its "Serum" Messenger, you're not just supporting the boom of messaging services, but also the highly successful app-pioneer behind the "Serum" application – Julian Ing.

Julian Ing, the head of Fundamental Applications Corp., is considered to be one of the pioneers of the social gaming industry. Games developed by Julian are among the most successful games on Facebook and Zynga and have received multiple awards. Now, with the first anonymous messenger, Julian Ing hopes to conquer the messenger market.

Currently, Fundamental shares are listed at EUR 0.20 and hold enormous potential. Based on the standard valuations of the messenger app sector, the shares should have a fair value of EUR 1.20 by the third quarter of 2015 – and this is only a conservative estimate.

A Snapchat user is currently valued at USD $382. A WeChat user is valued at USD $200. A WhatsApp user is "only" valued at USD $42. However, WhatsApp transactions are also the oldest by far and in the meantime the valuation of messaging apps has further increased.

Even if you halve the conservative WhatsApp valuation (USD $21 per user), Fundamental Apps could be worth EUR 17.1 million in the third quarter of 2015, which is EUR 1.20 per share. Within that time, the company plans to break through the barrier of 1 million users.

For the first time, private investors can invest in the app from the outset!

To date, only institutional investors could earn money through WhatsApp, Snapchat or WeChat. With its unique features, "Serum" has the potential to follow in the footsteps of these successful messaging apps.

As a listed shareholder of Fundamental Applications (CSE:FUN) (WKN: A12DSM/ISIN: CA36080U1003), there is an opportunity to profit from the success of a unique messaging app from the outset. The shares of Fundamental Applications are traded in Germany on the Frankfurt Stock Exchange WKN: A12DSM/ISIN: CA36080U1003 and in Canada on the Canadian Stock Exchange (CSE) under the symbol FUN.

The photo is also available via AP PhotoExpress.

www.funappcorp.com PH: 778 288 8492 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 36

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board

Updated Category News Views 103

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board AgEagle Aerial Systems Inc. (NYSE: UAVS), renowned for its top-tier unmanned aerial systems (UAS), is excited to announce the recent addition of Kevin Lowdermilk to its board of directors. His appointment, effective as of late October, marks a strategic enhancement to the company's leadership team, ensuring...

Continue Reading
Natera's Growth Continues Amid Legal Challenges and Market Wins

Updated Category News Views 413

Natera Faces Legal Challenges with Strong Market Performance Natera, Inc. (NASDAQ: NTRA) is a leader in the genetic testing industry, known for its groundbreaking contributions to oncology and women’s health. Recently, the company encountered an unfavorable jury decision in a legal battle concerning false advertising claims made against Guardant Health (NASDAQ: GH). The...

Continue Reading
Spreedly Sees Unprecedented Growth in Open Payments Sector

Updated Category News Views 110

Spreedly Surges Ahead in Open Payments Innovation Spreedly, a prominent leader in open payments, has recently showcased remarkable progress in revenue and customer expansion, marking a new chapter in the payment processing industry. With a growing clientele that spans across varied sectors, the company is redefining how digital transactions are handled worldwide. Key...

Continue Reading
Shelley Joyce Takes the Helm as CTO at TSG, Ramping Up Innovation

Updated Category News Views 431

TSG Appoints Shelley Joyce as New Chief Technology Officer In a significant move to enhance its technology initiatives, TSG (The Strawhecker Group) has announced the appointment of Shelley Joyce as the Chief Technology Officer (CTO). With her extensive background in the payments industry, Shelley is set to lead TSG’s technological advancements and cater to the evolving...

Continue Reading
Equillium Plans Engaging Event for Ulcerative Colitis Insights

Updated Category News Views 121

Equillium's Upcoming Event on Ulcerative Colitis Equillium, Inc. (NASDAQ: EQ), a biotechnology company focused on developing innovative therapeutics for autoimmune and inflammatory diseases, has announced an exciting virtual event featuring prominent thought leaders in the field of ulcerative colitis (UC). This event is scheduled for a Wednesday in November at 12 PM ET....

Continue Reading